Results of the Collaborative Initial Glaucoma Treatment Study (CIGTS)

被引：7

作者：

Wahl J. ^{[1
,2
]}

机构：

[1] Augenklinik, Universität, Mainz

[2] Augenklinik, Universität, 55131 Mainz

来源：

Der Ophthalmologe | 2005年 / 102卷 / 3期

关键词：

CIGTS; Collaborative Initial Glaucoma Treatment Study; Open-angle glaucoma; Progression of visual field; Trabeculectomy;

D O I：

10.1007/s00347-005-1173-y

中图分类号：

学科分类号：

摘要：

The Collaborative Initial Glaucoma Treatment Study (CIGTS) was initiated to evaluate whether local medical therapy or trabeculectomy is the better initial treatment for patients with newly diagnosed open-angle glaucoma. Visual field progression, intraocular pressure, and visual acuity were to be monitored for a period of 5 years. A total of 607 patients were randomly distributed among the two groups and controlled at 6-month intervals. At the same time the investigators tried to record quality of life using a questionnaire. Both trabeculectomy and medical therapy were able to lower intraocular pressure significantly, whereas trabeculectomy was more effective. The results of the questionnaire showed only minor differences between the two groups. The medically treated patients reported slightly more ocular symptoms than the patients in the trabeculectomy group. © Springer Medizin Verlag 2005.

引用

页码：222 / 226

页数：4

共 12 条

[1]

Feiner L., Piltz-Seymour J.R., Collaborative Initial Glaucoma Treatment Study: A summary of results to date, Curr Opin Ophthalmol, 14, pp. 106-111, (2003)

[2]

Janz N.K., Wren P.A., Lichter P.R., Musch D.C., Gillespie B.W., Guire K.E., Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study, Ophthalmology, 108, pp. 887-897, (2001)

[3]

Janz N.K., Wren P.A., Lichter P.R., Musch D.C., Gillespie B.W., Guire K.E., Mills R.P., The Collaborative Initial Glaucoma Treatment Study: Interim quality of life findings after initial medical or surgical treatment of glaucoma, Ophthalmology, 108, pp. 1954-1965, (2001)

[4]

Ma K., Heuer D.K., Higginbotham E.J., Et al., The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma, Arch Ophthalmol, 120, pp. 701-713, (2002)

[5]

Katz J., Congdon N., Friedman D.S., Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment, Arch Ophthalmol, 117, pp. 1137-1142, (1999)

[6]

Kim J.W., Freeman W.R., Azen S.P., El-Haig W., Klein D.J., Bailey I.L., Prospective randomized trial of vitrectomy or observation for stage 2 macular holes, Am J Ophthalmol, 121, pp. 605-614, (1996)

[7]

Leske M.C., Heijl A., Hussein M., Bengtsson B., Hyman L., Komaroff E., Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial, Arch Ophthalmol, 121, pp. 48-56, (2003)

[8]

Lichter P.R., Mills R.P., Group C.S., Quality of life: Study: Determination of progression, Encounters in Glaucoma Research 3: How to Ascertain Progression and Outcome, pp. 149-163, (1996)

[9]

Lichter P.R., Musch D.C., Gillespie B.W., Guire K.E., Janz N.K., Wren P.A., Mills R.P., Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery, Ophthalmology, 108, pp. 1943-1953, (2001)

[10]

Musch D.C., Lichter P.R., Guire K.E., Standardi C.L., The Collaborative Initial Glaucoma Treatment Study: Study design, methods, and baseline characteristics of enrolled patients, Ophthalmology, 106, pp. 653-662, (1999)

← 1 2 →